BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31038838)

  • 1. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
    Shaw J; de Wit C; Le Gal G; Carrier M
    J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer.
    Aziz J; Wang TF; Siegal D; Douketis J; Le Gal G; Carrier M; Shaw JR
    J Thromb Haemost; 2023 Apr; 21(4):933-943. PubMed ID: 36696183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
    Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL
    J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
    Brown JD; Goodin AJ; Lip GYH; Adams VR
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients.
    Tafur AJ; Wysokinski WE; McBane RD; Wolny E; Sutkowska E; Litin SC; Daniels PR; Slusser JP; Hodge DO; Heit JA
    Ann Oncol; 2012 Aug; 23(8):1998-2005. PubMed ID: 22473596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
    Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
    JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.
    Vasanthamohan L; Boonyawat K; Chai-Adisaksopha C; Crowther M
    J Thromb Haemost; 2018 Jul; 16(7):1288-1295. PubMed ID: 29772108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV
    Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.
    Schulman S; Zondag M; Linkins L; Pasca S; Cheung YW; de Sancho M; Gallus A; Lecumberri R; Molnar S; Ageno W; Le Gal G; Falanga A; Hulegårdh E; Ranta S; Kamphuisen P; Debourdeau P; Rigamonti V; Ortel TL; Lee A
    J Thromb Haemost; 2015 Jun; 13(6):1010-8. PubMed ID: 25851122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural anticoagulation management of patients with venous thromboembolism.
    McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
    Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
    Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.
    Kim BJ; Day RW; Davis CH; Narula N; Kroll MH; Tzeng CWD; Aloia TA
    J Thromb Haemost; 2017 Nov; 15(11):2158-2164. PubMed ID: 28846822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
    Nagler M; Angelillo-Scherrer A; Méan M; Limacher A; Abbal C; Righini M; Beer JH; Osterwalder J; Frauchiger B; Aschwanden M; Matter CM; Kucher N; Cornuz J; Banyai M; Husmann M; Staub D; Mazzolai L; Hugli O; Rodondi N; Aujesky D
    J Thromb Haemost; 2017 Nov; 15(11):2165-2175. PubMed ID: 28834238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.
    Palareti G; Antonucci E; Mastroiacovo D; Ageno W; Pengo V; Poli D; Testa S; Tosetto A; Prandoni P
    J Thromb Haemost; 2018 Oct; 16(10):1994-2002. PubMed ID: 30059189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
    Schnegg-Kaufmann A; Calzavarini S; Limacher A; Mean M; Righini M; Staub D; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Husmann M; Banyai M; Aschwanden M; Mazzolai L; Hugli O; Nagler M; Daskalakis M; Rodondi N; Aujesky D; Angelillo-Scherrer A
    J Thromb Haemost; 2019 Feb; 17(2):306-318. PubMed ID: 30570809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
    Carrier M; Le Gal G; Wells PS; Rodger MA
    Ann Intern Med; 2010 May; 152(9):578-89. PubMed ID: 20439576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.